Erythropoietin Enhances Iron Bioavailability in HepG2 Cells by Downregulating Hepcidin through mTOR, C/EBPα and HIF-1α

The authors showed that erythropoietin inhibited hepcidin expression directly in the HepG2 hepatic cell line, thus leading to a decrease in intracellular Fe levels.